SALT LAKE CITY – Pretransplant JAK inhibitor therapy may improve posttransplant survival in patients with myelofibrosis, according to a phase 2...
Indiana’s waiver requires certain Medicaid recipients to work or volunteer at least 20 hours a week to qualify for health care coverage.
More patients are getting chemotherapy in the hospital, even though the price is twice as high.
Breaking and entering? Is it time for health care providers to buy cyberpolicies in case of expensive data breaches?
The FDA has granted breakthrough therapy designation to a gene therapy product aimed at hemophilia A.
LA JOLLA, CALIF. – The phase 1 trial is testing the use of a CD25 monoclonal antibody for achieving long-term remission in PTCL.
The plans could add more, lower-cost choices and could lead to broader provider networks than ACA plans in rural areas, according to the proposed...
News from the FDA/CDC
The FDA is expected to make a decision in August 2018.
ATLANTA – The 7-year findings could lead to a new strategy for the treatment of high-risk patients with APL.
From the Journals
The research could set the stage for therapeutic targets to help avoid drug resistance in mantle cell treatment.